CFTR and cystic fibrosis: Members of the Lancet Respiratory Medicine Committee on the Future of Cystic Fibrosis Care (Bell et al.)pointed to various challenges related to the changing landscape of cystic fibrosis care and the possibilities for progress in its treatment, with particular emphasis on advances in CFTR-modulating therapies to address the underlying CF defect [29].